Agoracom Blog Home

Archive for the ‘Universal PropTech Inc.’ Category

VIDEO – Universal PropTech $UPI CGO Frank Delves Into The Company’s Future $UPI.ca $AAT.ca $LPS.ca $EGT.ca

Posted by AGORACOM-JC at 4:33 PM on Tuesday, March 30th, 2021

VIDEO – An Introduction to Universal PropTech Inc. $UPI.ca $AAT.ca $LPS.ca $EGT.ca

Posted by AGORACOM-JC at 3:46 PM on Tuesday, March 30th, 2021

Universal PropTech $UPI Provides Update on SpotLight-19(C) – Designed to Detect COVID-19 in Under 20 Seconds and at a Cost of Approximately $1 Per Test $AAT.ca $LPS.ca $EGT.ca

Posted by AGORACOM-JC at 9:48 AM on Tuesday, March 9th, 2021
  • ISBRG Corp (“ISBRG“) has posted a number of updates on their website (www.isbrgcorp.com) regarding their SpotLight-19© Technology
  • Updated the expected COVID-19 detection time to under 20 seconds, at an approximate cost of $1 per COVID-19 test, an expanded list of solutions, and adding an additional advisor to the Advisory Board.

Toronto, Ontario–(March 9, 2021) –  Universal PropTech Inc. (TSXV:UPI) (FSE:8LH) (“UPI” or the “Company“) is pleased to announced that ISBRG Corp (“ISBRG“) has posted a number of updates on their website (www.isbrgcorp.com) regarding their SpotLight-19© Technology including updating the expected COVID-19 detection time to under 20 seconds, at an approximate cost of $1 per COVID-19 test, an expanded list of solutions, and adding an additional advisor to the Advisory Board.

ISBRG’s SpotLight-19© technology leverages advancements in optics and artificial intelligence to define a state of COVID-19 infection.

SpotLight-19© (which upon testing to establish specificity and sensitivity ISBRG intends to submit for regulatory approval) is designed to screen for a unique infectious state – within 20 seconds of scanning a fingertip with light. ISBRG is undertaking trials to determine SpotLight-19©’s efficacy in detecting COVID-19, and if proven effective, will be subject to further regulatory approvals before it would be commercially available.

The speed and estimated cost of the test (approximately one dollar), combined with the non-invasive nature of light (no body fluid of any kind is required), is intended to accommodate the testing of large numbers of people without the inconvenient delays and environmental damage associated with current chemical reagent-based tests.

Below is an image of a finger over the beam of light from ISBRG Corp’s SpotLight-19 device.

 ISBRG Corp’s SpotLight-19 device

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/5341/76555_e6bb61ceb4a639fe_002full.jpg

We are very excited that ISBRG has begun to inform the world of the high expectations for SpotLight-19,” commented Chris Hazelton, President and CEO of UPI. “Pending further testing and submission for regulatory approval, a 20-second COVID-19 test will open the global economy, and at an approximate cost of $1 per test, will enable governments around the world to afford and adopt rapid testing for COVID-19. We look forward to the results of ISBRG’s clinical trials and we have high hopes for its success. Once shown to be effective in testing for COVID-19, we expect other applications to follow.”

The global COVID-19 diagnostics market size is estimated at USD$84.4 billion in 2020 and is expected to expand at a compounded annual growth rate (CAGR) of 3.1% from 2021 to 2027[1].

In addition, the ISBRG website adds that ISBRG’s technology is designed for other applications, including for viral infection – screening technology to detect unique infections, including COVID-19; drug impairment – defining a unique state of impairment (such as THC); athletic fitness – defining a state of optimal fitness performance; nutritional health – defining the impact of dietary and / or supplement choices; healthy aging – defining the impact of gradual lifestyle changes and aging; and adolescent health – defining the impact of early stage lifestyle, exercise and nutrition decisions.

Read More: https://agoracom.com/ir/UniversalPropTech/forums/discussion/topics/756884-universal-proptech-inc-provides-update-on-spotlight-19c-designed-to-detect-covid-19-in-under-20-seconds-and-at-a-cost-of-approximately-1-per-test/messages/2307213#message

Universal PropTech $UPI Announces #OTC Application Filing $AAT.ca $LPS.ca $EGT.ca

Posted by AGORACOM-JC at 9:06 AM on Thursday, March 4th, 2021
  • Filed an application to be quoted on the OTCQB, a U.S. market operated by OTC Markets Group Inc. in New York.
  • The Company will continue to trade on the TSX Venture Exchange under its symbol “UPI” and the Frankfurt Stock Exchange under its symbol “8LH”.
  • In addition, the Company is working to secure DTC eligibility with The Depository Trust Company for electronic settlement and transfer of its common shares in the United States.

Toronto, Ontario–(March 4, 2021) – Universal PropTech Inc. (TSXV: UPI) (FSE: 8LH) (“UPI” or the “Company“) is pleased to announce that is has filed an application to be quoted on the OTCQB, a U.S. market operated by OTC Markets Group Inc. (“OTC“) in New York. The Company will continue to trade on the TSX Venture Exchange under its symbol “UPI” and the Frankfurt Stock Exchange under its symbol “8LH”. In addition, the Company is working to secure DTC eligibility with The Depository Trust Company (“DTC“) for electronic settlement and transfer of its common shares in the United States.

Chris Hazelton, CEO of Universal PropTech commented, “UPI is excited to provide US institutional and retail investors this opportunity to join our journey through the OTCQB.” Mr. Hazelton continued, “We love our Canadian roots, but our plans and visions include being traded in the largest economy on the planet and demonstrate our investment capabilities in technologies with global impacts, such as SpotLight19.”

The OTC operates the world’s largest electronic interdealer quotation system for US broker dealers and offers multiple media channels to increase the visibility of OTC-listed companies. Trading on the OTCQB market enables companies to efficiently build broader investor awareness and provide U.S. investors with a seamless trading facility to more easily trade through the broker of their choice.

Obtaining quotation of the Company’s common shares on the OTCQB remains subject to the approval of the OTCQB and the satisfaction of applicable listing requirements. The quotation of Universal PropTech shares is expected to begin upon securing the approval from the OTC. As more information becomes available, the Company will keep its shareholders up-to-date on the status of the application.

Read More: https://agoracom.com/ir/UniversalPropTech/forums/discussion/topics/756563-universal-proptech-inc-announces-otc-application-filing/messages/2306466#message

VIDEO – Universal PropTech $UPI Secures Investment and Rights To Finger Scan Test Designed To Detect COVID-19 In Less Than A Minute $AAT.ca $LPS.ca $EGT.ca

Posted by AGORACOM-JC at 6:04 PM on Thursday, February 18th, 2021

As the name implies “PropTech” is a combination of two words and stands for “property technology.”  As simple as that is, the implementation and importance of PropTech is anything but, which is why many companies are trying to capitalize on the rapidly growing paradigm shift, while Universal PropTech (UPI:TSXV) is actually delivering healthy building solutions developers, owners and operators across Canada. 

More than just lip service, UPI clients include:

· Federal Government facilities for over 40 years 

· Manulife 

· Brookfield 

· Billy Bishop Airport 

· University of Toronto 

· …. and many more 

As a result, UPI has generated $35,000,000+ in revenue over the past 3 year – a number most small cap companies would be very happy with.  But newly appointed Chief Growth Officer, Frank Carnevale sees a much bigger opportunity by winning exclusive licenses and partnerships with providers of great products that can significantly grow company revenues … and he has delivered pretty strongly against this mission statement in 2021. 

BUT TODAY HE TOOK A GIANT LEAP FORWARD 

The press release headline says it all:

Universal PropTech Inc. Invests in and Secures defined Agency Rights for ISBRG Corp.’s SpotLight-19(C) Technology Designed to Detect Covid-19 Non-Invasively in Under One Minute  

In short, this technology takes a non-invasive scan of a person’s finger with a harmless beam of light designed to provide confirmation of Covid-19 infection in less than 1 minute.  

How significant is this announcement and what does it mean to the Company’s growth? 

Watch our interview with CGO Carnevale to learn all about it. 

Universal PropTech $UPI Invests in and Secures defined Agency Rights for ISBRG Corp.’s SpotLight-19(C) Technology Designed to Detect Covid-19 Non-Invasively in Under One Minute $AAT.ca $LPS.ca $EGT.ca

Posted by AGORACOM-JC at 9:57 AM on Thursday, February 18th, 2021
  • ISBRG is a data analytics company which has developed the SpotLight technology platform designed to generate comprehensive health care data non-invasively within seconds at a nominal incremental cost per test.
  • SpotLight-19© is non-invasive, and ISBRG is undertaking trials to determine efficacy in detecting Covid-19.
  • In addition to its minority investment, UPI will act as the exclusive sales agent for the SpotLight-19© technology and other future platform offerings for the government and education sectors in Canada.

Toronto, Ontario–(February 18, 2021) – Universal PropTech Inc. (TSXV: UPI) (“UPI” or the “Company”) is pleased to announce that it has completed an investment in ISBRG Corp. (“ISBRG”) for a minority interest, and secured agency rights to their SpotLight-19© Technology.

ISBRG is a data analytics company which has developed the SpotLight technology platform designed to generate comprehensive health care data non-invasively within seconds at a nominal incremental cost per test. SpotLight-19© is non-invasive, and ISBRG is undertaking trials to determine efficacy in detecting Covid-19. In addition to its minority investment, UPI will act as the exclusive sales agent for the SpotLight-19© technology and other future platform offerings for the government and education sectors in Canada.

“We are proud and excited to be a strategic investor in ISBRG,” stated Chris Hazelton, President & CEO of Universal PropTech. “We have been committed to ensuring safe and healthy workspaces for our clients and facilitating the return of workers to workspaces in the face of the pandemic, and SpotLight-19© as a rapid, inexpensive and reusable testing platform to ensure safe work environments, could be a catalyst to opening global economies. Upon completion of trials and relevant governmental approvals, Universal PropTech expects that it will aggressively market SpotLight-19© products and supporting services to all governmental and education providers across Canada.”

“Our technology stems from the belief that technological innovation and strategic partnerships will restore economic growth globally in the midst of a pandemic that is challenging the speed, accuracy and effectiveness of existing tests” stated Duncan MacIntyre, Founder and CEO ISBRG.

ISBRG’s SpotLight-19© technology platform has proof of concept, and the funding now enables trials to determine the sensitivity and specificity of the device which will be compared to the accuracy of PCR tests in upcoming trials which are subject to authorization by Health Canada and REB review. Several published studies support ISBRG’s proof of concept and the application of light to detect viruses has been well documented in the past, see (https://pubmed.ncbi.nlm.nih.gov/29806030/).

The global Covid-19 diagnostics market size is estimated at USD$84.4 billion in 2020 and is expected to expand at a compounded annual growth rate (CAGR) of 3.1% from 2021 to 2027[1].

ISBRG headquartered in Mississauga, Ontario, developed its SpotLight-19© technology platform to monitor health – including a Covid-19 state of infection – using patent pending proprietary applications utilizing machine learning, optics and non-invasive interface design.

SpotLight-19© technology platform features:

  • a non-invasive scan of a person’s finger with a harmless beam of light
  • designed to provide confirmation of Covid-19 infection in less than 1 minute
  • low-cost testing.

ISBRG’s SpotLight-19© technology is intended for use in large venues, such as:

  • airports
  • border crossings
  • government buildings
  • schools and campuses
  • entertainment complexes, etc.

Should your organization wish to express an interest in procuring SpotLight-19©, please link and complete the Contact form. https://universalproptech.com/

ISBRG founder Duncan MacIntyre, is the former President of ICI in Canada and Latin America, the founding President of the National Quality Institute and co-author of more than 25 US patents in the field of spectroscopy. He has assembled a team of medical doctors, Ai specialists, hardware designers, internationally recognized optics experts and an ISBRG Board of Advisors that excel in their respective fields. The Board of Advisors includes:

  • former Global VP of AMGEN – Michael Kelly
  • former Canadian Astronaut and Author – Commander Chris Hadfield
  • former Director of Emera and Order of Canada appointee – Irene d’Entremont
  • former President of American Eagle Airlines – Peter Bowler
  • former Director General Global Operations CSIS – Allan MacDougall

Michael Kelly, former AMGEN Global VP, Thousand Oaks, California, states: “I became involved in ISBRG because of SpotLight-19©’s Ai and optical design innovations which, subject to confirmation in these trials, have the potential to significantly impact the global economic recovery more than any other technology available today”.

Read More: https://agoracom.com/ir/UniversalPropTech/forums/discussion/topics/755586-universal-proptech-inc-invests-in-and-secures-defined-agency-rights-for-isbrg-corp-s-spotlight-19-c-technology-designed-to-detect-covid-19/messages/2304191#message

VIDEO – Universal PropTech $UPI Has Generated $35,000,000+ In Revenues Over Past 3 Years – But Chief Growth Officer Carnevale Sets Up For Big Growth In 2021 $AAT.ca $LPS.ca $EGT.ca

Posted by AGORACOM-JC at 5:29 PM on Thursday, February 11th, 2021

As the name implies “PropTech” is a combination of two words and stands for “property technology.”  As simple as that is, the implementation and importance of PropTech is anything but, which is why many companies are trying to capitalize on the rapidly growing paradigm shift, while Universal PropTech (UPI:TSXV) is actually delivering healthy building solutions developers, owners and operators across Canada.

More than just lip service, UPI clients include

  • Federal Government facilities for over 40 years
  • Manulife
  • Brookfield
  • Billy Bishop Airport
  • University of Toronto
  • …. and many more

As a result, UPI has generated $35,000,000+ in revenue over the past 3 year – a number most small cap companies would be very happy with.  But newly appointed Chief Growth Officer, Frank Carnevale sees a much bigger opportunity by winning exclusive licenses and partnerships with providers of great products that can significantly grow company revenues. 

And that’s exactly what he has done.  In the month of FEBRUARY alone, UPI has announced:

 Agreement with LuminUltra Technologies to Provide SARS-CoV-2 (COVID-19) Surface Testing

Channel Partnership with SensorSuite Inc. to Deliver AI Building Automation for MURBs and Non-BAS Customers

Exclusive Distributor Agreement for Eastern Canada for Canadian-Made Air Sanitization Solutions

How significant are these announcements and what do they mean to the Company’s growth?  

Watch our interview with CGO Carnevale to learn about these and where UPI is going.

Universal PropTech Inc. $UPI.ca Announces Agreement with LuminUltra Technologies to Provide SARS-CoV-2 #COVID19 Surface Testing #AI #IoT $SNE $MSFT $HON

Posted by AGORACOM-JC at 9:51 AM on Tuesday, February 9th, 2021
  • Entered into an agreement on February 5, 2021 with LuminUltra Technologies Ltd. to deploy their GeneCount Rapid SARS-CoV-2 surface testing solution for UPI’s current and past customers which total over 2,000 facilities including certain aviation assets in Canada today.
  • The Agreement provides UPI the ability to provide testing services employing LuminUltra’s GeneCount® qPCR tests as a service.

Toronto, Ontario–(February 9, 2021) – Universal PropTech Inc. (TSXV: UPI) (“UPI” or the “Company“) is pleased to announce that is has entered into an agreement on February 5, 2021 with LuminUltra Technologies Ltd. (“LuminUltra“) to deploy their GeneCount Rapid SARS-CoV-2 surface testing solution for UPI’s current and past customers which total over 2,000 facilities including certain aviation assets in Canada today. The Agreement provides UPI the ability to provide testing services employing LuminUltra’s GeneCount® qPCR tests as a service.

Chris Hazelton, President and CEO of UPI commented: “We are very excited to bring LuminUltra’s highly reputable SARS-CoV-2 surface testing solution to our customer base in Canada to ensure workplaces are sanitary and safe,” Mr. Hazelton continued: “We had committed strategically to expanding our product mix and investing in key technology to enhance our Trusted Advisor status with our customers. Coupled with our recent announcements, the addition of LuminUltra’s surface testing technology to our suite of services, we are well on our way to meeting that commitment to customers and shareholders.”

UPI’s wholly owned operating subsidiary, VCI Controls, will utilize the LimunUltra GeneCount® qPCR test in order to provide audit support for the efficacy of the various indoor air quality equipment it is installing in customer facilities. In this way, VCI Controls will be able to provide clients with data demonstrating the real world effectiveness of the air sanitization equipment it installs, along with peace of mind for owners and staff alike that Covid-19 is not present in their facilities.

LuminUltra provides testing solutions for clinical diagnostics, surface, and wastewater testing. LuminUltra, through its rapid, accurate and portable qPCR tests help safeguard and protect environments by providing verification of disinfection protocols to confirm the absence of the SARS-CoV-2 virus. This helps identify early warning signs which enables the execution of swift response including contact tracing and human testing.

Fully Portable Manual Testing Using GeneCount® Q-16

To view an enhanced version of this image, please visit:
https://orders.newsfilecorp.com/files/5341/74003_45bb8bd3e4ec081a_002full.jpg

Read More: https://agoracom.com/ir/UniversalPropTech/forums/discussion/topics/754978-universal-proptech-inc-announces-agreement-with-luminultra-technologies-to-provide-sars-cov-2-covid-19-surface-testing/messages/2302823#message

Universal PropTech Inc. $UPI.ca Announces Channel Partnership with SensorSuite Inc. to Deliver AI Building Automation for MURBs and Non-BAS Customers #AI #IoT $SNE $MSFT $HON

Posted by AGORACOM-JC at 8:29 AM on Wednesday, February 3rd, 2021
  • Entered into a channel partnership agreement with SensorSuite Inc. to deliver SensorSuite’s Artificial Intelligence Energy Cloud Ecosystem Platform to multi-unit residential building and non-BAS customers across Canada
  • SensorSuite’s E.C.E platform seamlessly monitors, controls and optimizes Electricity, Gas and Water assets.
  • Using AI algorithms, the Energy Cloud Ecosystem aggregates and co-ordinates Distributed Energy Resources to eliminate wastage and increase operational efficiency.

Toronto, Ontario–(February 3, 2021) – Universal PropTech Inc. (TSXV: UPI) (“UPI” or the “Company“) is pleased to announce that it has entered into a channel partnership agreement (“Agreement“) with SensorSuite Inc. (“SensorSuite“) to deliver SensorSuite’s Artificial Intelligence (“AI“) Energy Cloud Ecosystem (“E.C.E“) Platform to multi-unit residential building (“MURB”) and non-BAS customers across Canada.

“Universal PropTech is pleased to bring SensorSuite’s AI platform to our MURB customers and prospects,” stated Chris Hazelton, President and CEO of UPI. “The inclusion of Artificial Intelligence is another tool in our expanding Building Performance offering to improve our evidence-based approach, ongoing services revenues and sustain our Trusted Advisor status.”

SensorSuite’s E.C.E platform seamlessly monitors, controls and optimizes Electricity, Gas and Water assets. Using AI algorithms, the Energy Cloud Ecosystem aggregates and co-ordinates Distributed Energy Resources to eliminate wastage and increase operational efficiency.

SensorSuite has deployed their AI solution in over 157 MURBs in Canada generating 12 billion data points per year. The Energy Cloud Ecosystem can generate between 20% to 30% in energy efficiency for MURB owners and managers, in an ongoing service model.

VCI Controls, a UPI wholly owned subsidiary, has provided services to over 2000 buildings in over 40 years, and will assess opportunities to generate Building Performance revenues with past, current customers and new prospects.

Glen Spry, President and CEO of SensorSuite, “We are excited to have Universal PropTech actively drive sales in Canada. Having a 40-year controls company like VCI Controls, enables us to start to scale the success of our AI Energy Cloud Ecosystem Platform.”

Read More: https://agoracom.com/ir/UniversalPropTech/forums/discussion/topics/754518-universal-proptech-inc-announces-channel-partnership-with-sensorsuite-inc-to-deliver-ai-building-automation-for-murbs-and-non-bas-customers/messages/2301770#message

Universal PropTech Inc. $UPI.ca Announces Signing of Exclusive Distributor Agreement for Eastern Canada for Canadian-Made Air Sanitization Solutions #AI #IoT $SNE $MSFT $HON

Posted by AGORACOM-JC at 8:28 AM on Monday, February 1st, 2021
  • Entered into an exclusive master distributor agreement with Air Alpine Innovation Research Inc. to promote and market Air Sniper products.
  • UPI’s wholly-owned subsidiary, VCI Controls Inc. will exclusively distribute these products in Ontario, Quebec and Atlantic Canada.
  • We are excited to exclusively represent this Made-in-Canada success story of leading edge germicidal UVC and NASA-originated Photocatalytic Oxidation technology in Ontario, Quebec and Atlantic Canada,” stated Chris Hazelton,

Toronto, Ontario–(February 1, 2021) – Universal PropTech Inc. (TSXV: UPI) (“UPI” or the “Company“) is pleased to announce that it has entered into an exclusive master distributor agreement (“Agreement“) with Air Alpine Innovation Research Inc. (“Air Sniper“) to promote and market Air Sniper products. UPI’s wholly-owned subsidiary, VCI Controls Inc. (“VCI“) will exclusively distribute these products in Ontario, Quebec and Atlantic Canada.

We are excited to exclusively represent this Made-in-Canada success story of leading edge germicidal UVC and NASA-originated Photocatalytic Oxidation technology in Ontario, Quebec and Atlantic Canada,” stated Chris Hazelton, President and CEO of UPI. “We will aggressively pursue immediate opportunities in schools, campuses, government and commercial facilities and seniors’ homes.”

Stuart Henley, President of Air Sniper said, “Air Sniper is pleased to enter into a partnership with Universal PropTech, and to be able to utilize their 40-year presence and experience in Ontario, Quebec and Atlantic Canada. With UPI’s existing and expanding client footprint, we expect to develop a strong partnership and see significant adoption as we work to push the Air Sniper product through sales funnels.”

Read More: https://agoracom.com/ir/UniversalPropTech/forums/discussion/topics/754321-universal-proptech-inc-announces-signing-of-exclusive-distributor-agreement-for-eastern-canada-for-canadian-made-air-sanitization-solutions/messages/2301345#message